Orient Pharma Co., Ltd. Yunlin Plant is recalling 78,122 bottles of Pitavastatin (pitavastatin) tablets, including 57,504 bottles of the 2 mg strength and 20,618 bottles of the 1 mg strength. These prescription medications, manufactured for Teva Pharmaceuticals, were found to fail quality specifications for impurities and degradation during testing. If you are currently taking this medication, you should consult your healthcare provider or pharmacist before making any changes to your treatment.
The affected tablets may contain impurities or have broken down (degraded) beyond the levels permitted by pharmaceutical standards. This can potentially make the medication less effective or lead to exposure to unintended chemical byproducts, though the safety risk is currently categorized by the FDA as low.
You have 2 options:
Manufactured for Teva Pharmaceuticals, Parsippany, NJ.
Manufactured for Teva Pharmaceuticals, Parsippany, NJ.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.